Atlas Trials

Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults

Clinical trial NCT05219968 · COMPLETED

Trial details

NCT number
NCT05219968
Sponsor
Lyra Therapeutics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic SinusitisChronic Rhinosinusitis (Diagnosis)
Start date
2022-01-27
Primary completion
2024-03-04
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.